ACADEMICIA: An International Multidisciplinary Research Journal
  • Year: 2021
  • Volume: 11
  • Issue: 10

Comparative efficiency of the preparation "Nodinorm" in complex treatment of fibrocystic mastopathy

  • Author:
  • Shoxista Sharofiddin Qizi Meliboyeva, Mizrob Mavlonovich Boltayev, Elvina Midatovna Sharipova, Riboba Gulomaliyevna Sharipova
  • Total Page Count: 6
  • Page Number: 1591 to 1596

*Assistant, Department of Pharmacology and Clinical Pharmacology, Bukhara State Medical Institute, Uzbekistan

Online Published on 07 January, 2022.

Abstract

The pathology of the mammary gland is represented by such diseases as acute and chronic mastitis, fibrocystic mastopathy, gynecomastia, benign and malignant neoplasms, among which the greatest danger is cancer. Among nosological units, fibrocystic mastopathy occupies a special place, which, according to various authors, affects from 50 to 90% of women. Most often, women are sick at the age of 40–50 years. These changes in breast tissue are benign, but patients with mastopathy are at high risk of cancer [3]. A possible solution to the problem of treating patients with combined pathology of the uterus and mammary glands is the use of the domestic drug "Nodinorm" in the complex treatment of the main substance, which is indole-3-carbinol.

Keywords

Fibrocystic Mastopathy, Benign Tumor, Broccoli, Estrogens, Indole-3-Carbinol, Pharmaceutical Company Naturex, Nodinorm, Pharmaceutical Company Evalar, Indol-Forte